Literature DB >> 6266704

beta-lipotrophin and beta-endorphin plasma levels during pregnancy.

A R Genazzani, F Facchinetti, D Parrini.   

Abstract

beta-lipotrophin (beta-LPH) and beta-endorphin (beta-EP) plasma levels were measured by radioimmunoassay after glass powder extraction and Sephadex G-75 column chromatography in plasma samples from controls (ten healthy males and twenty-six young women in early follicular phase), from eighty-two pregnant women in weeks 9-40 after their last menstrual period, from nine women just after delivery and the cord blood of their neonates, in fifteen mixed cord blood samples and in seven amniotic fluid samples obtained by amniocentesis. No sex differences were found in beta-LPH (120.6 +/- 8.5 pg/ml) or beta-EP (31.1 +/- 2.4 pg/ml) plasma levels or in their molar ratio (1.34 +/- 0.09) (MR). beta-LPH plasma levels increased in early pregnancy (13-16 weeks) (185.0 +/- 27.1 pg/ml) and remained high until weeks 21-24, then declining to levels similar to those of controls. beta-EP plasma levels were significantly depressed in weeks 9-12 (20.7 +/- 5.3 pg/ml), subsequently increasing to a maximum at weeks 36-37 (42.7 +/- 6.8 pg/ml). beta-LPH/beta-EP molar ratio was about double normal in early pregnancy and decreased to normal in the second half. The present data indicate that beta-LPH and beta-EP present different patterns throughout pregnancy and that beta-EP levels increase progressively, reaching the highest concentrations at term. At delivery, both beta-LPH and beta-EP showed maximum values (beta-LPH: 230.2 +/- 20.4 pg/ml; beta-EP: 78.0 +/- 7.4 pg/ml) and a MR of 1.02 +/- 0.10 indicating that stressful situations, such as labour, stimulate a simultaneous rise in beta-LPH and beta-EP plasma levels. Cord blood specimens showed a wide range of values (beta-LPH:75-347 pg/ml; beta-EP: 16-287 pg/ml) with a MR of 1.21 +/- 0.14. Amniotic fluid samples obtained late in the third trimester of pregnancy were characterized by beta-LPH levels of 119.4 +/- 26.4 pg/ml and beta-EP levels of 29.6 +/- 7.5 pg/ml.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6266704     DOI: 10.1111/j.1365-2265.1981.tb00628.x

Source DB:  PubMed          Journal:  Clin Endocrinol (Oxf)        ISSN: 0300-0664            Impact factor:   3.478


  9 in total

1.  [Endorphins and related opioids in the female].

Authors:  W Distler
Journal:  Arch Gynecol Obstet       Date:  1987       Impact factor: 2.344

2.  Epidural morphine prophylaxis of postoperative pain: report of a double-blind multicentre study.

Authors:  W D Writer; J B Hurtig; D Evans; R E Needs; C E Hope; J B Forrest
Journal:  Can Anaesth Soc J       Date:  1985-07

Review 3.  Enkephalins and Endorphins. Clinical, pharmacological and therapeutic implications.

Authors:  D L Copolov; R D Helme
Journal:  Drugs       Date:  1983-12       Impact factor: 9.546

Review 4.  Clinical review of headache in pregnancy.

Authors:  Paola Torelli; G Allais; G C Manzoni
Journal:  Neurol Sci       Date:  2010-06       Impact factor: 3.307

Review 5.  Migraine in pregnancy: what are the safest treatment options?

Authors:  V Pfaffenrath; M Rehm
Journal:  Drug Saf       Date:  1998-11       Impact factor: 5.606

6.  Adrenocorticotropic hormone and catecholamines in maternal, umbilical and neonatal plasma in relation to vaginal delivery.

Authors:  A Costa; V De Filippis; M Voglino; G Giraudi; M Massobrio; C Benedetto; L Marozio; M Gallo; G Molina; C Fabris
Journal:  J Endocrinol Invest       Date:  1988-11       Impact factor: 4.256

7.  Puerperal breast feeding does not stimulate circulating opioids in humans.

Authors:  A R Genazzani; F Facchinetti; D Parrini; F Petraglia; R La Rosa; R Puggioni; N D'Antona
Journal:  J Endocrinol Invest       Date:  1982 Nov-Dec       Impact factor: 4.256

8.  Neurohormones regulate T cell function.

Authors:  W Heagy; M Laurance; E Cohen; R Finberg
Journal:  J Exp Med       Date:  1990-05-01       Impact factor: 14.307

9.  Septic shock and sepsis syndrome in obstetric patients.

Authors:  P G Pryde; B Gonik
Journal:  Infect Dis Obstet Gynecol       Date:  1994
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.